{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:12:24Z","timestamp":1770333144363,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271695"],"award-info":[{"award-number":["81271695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471774"],"award-info":[{"award-number":["81471774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation of Third Military Medical University","award":["2014XJY04"],"award-info":[{"award-number":["2014XJY04"]}]},{"DOI":"10.13039\/501100004602","name":"Program for New Century Excellent Talents in University","doi-asserted-by":"crossref","award":["NCET-13-0703"],"award-info":[{"award-number":["NCET-13-0703"]}],"id":[{"id":"10.13039\/501100004602","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.biomaterials.2015.07.023","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T07:07:31Z","timestamp":1436857651000},"page":"169-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells"],"prefix":"10.1016","volume":"67","author":[{"given":"Qing","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2015.07.023_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (Taxol) across the blood-brain barrier in\u00a0vitro and in\u00a0vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib3","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1158\/0008-5472.CAN-08-2747","article-title":"Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP","volume":"69","author":"Dong","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib4","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib6","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.addr.2013.09.018","article-title":"Multidrug resistance: physiological principles and nanomedical solutions","volume":"65","author":"Kunjachan","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib7","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.addr.2013.09.017","article-title":"Nanotechnology approaches for personalized treatment of multidrug resistant cancers","volume":"65","author":"Minko","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib8","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.addr.2013.08.006","article-title":"Rationally designed nanovehicles to overcome cancer chemoresistance","volume":"65","author":"Livney","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/nnm.10.35","article-title":"Nanomedicinal strategies to treat multidrug-resistant tumors: current progress","volume":"5","author":"Dong","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib10","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","article-title":"Nanomedicine therapeutic approaches to overcome cancer drug resistance","volume":"65","author":"Markman","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib11","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1021\/mp500298q","article-title":"Pluronics and MDR reversal: an update","volume":"11","author":"Alakhova","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2011.01.024","article-title":"Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in\u00a0vitro","volume":"152","author":"Kievit","year":"2011","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1158\/0008-5472.CAN-11-2890","article-title":"Nanocarriers enhance doxorubicin uptake in drug-resistant ovarian cancer cells","volume":"72","author":"Arora","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2012.04.034","article-title":"Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes","volume":"161","author":"Nieto Montesinos","year":"2012","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0142-9612(99)00125-8","article-title":"Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles","volume":"21","author":"Soma","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2009.01.021","article-title":"Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance","volume":"136","author":"Patil","year":"2009","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib17","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1021\/nn2013707","article-title":"Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin","volume":"5","author":"Xiong","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2014.09.001","article-title":"Nanocarrier mediated delivery of siRNA\/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances","volume":"194","author":"Gandhi","year":"2014","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib19","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/adma.201100679","article-title":"Facile engineering of biocompatible materials with pH-modulated degradability","volume":"23","author":"Zhang","year":"2011","journal-title":"Adv. Mater"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib20","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1016\/j.biomaterials.2013.02.035","article-title":"A\u00a0pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib21","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1016\/j.biomaterials.2013.03.068","article-title":"Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel","volume":"34","author":"He","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib22","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1016\/j.biomaterials.2014.02.009","article-title":"Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector","volume":"35","author":"Liu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1166\/jbn.2015.2009","article-title":"Engineering of biocompatible pH-responsive nanovehicles from acetalated cyclodextrins as effective delivery systems for tumor therapy","volume":"11","author":"Zhang","year":"2015","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3565(24)41709-6","article-title":"Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus","volume":"297","author":"Arima","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.leu.2400659","article-title":"Flow cytometric analysis of P-glycoprotein function using rhodamine 123","volume":"11","author":"Petriz","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-3565(24)29254-5","article-title":"Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization","volume":"299","author":"Batrakova","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib27","first-page":"4926","article-title":"Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562\/ADM cells","volume":"48","author":"Hamada","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/rheumatology\/kem368","article-title":"Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes","volume":"47","author":"Byun","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.toxlet.2013.05.004","article-title":"Cytotoxic effects of incense particles in relation to oxidative stress, the cell cycle and F-actin assembly","volume":"220","author":"Chuang","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: opportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer conjugates as anticancer nanomedicines","volume":"6","author":"Duncan","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib37","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.addr.2013.08.004","article-title":"Nanopreparations to overcome multidrug resistance in cancer","volume":"65","author":"Patel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib38","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.addr.2013.09.004","article-title":"Biophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticles","volume":"65","author":"Peetla","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nrd1576","article-title":"Cyclodextrin-based pharmaceutics: past, present and future","volume":"3","author":"Davis","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib40","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.addr.2013.05.001","article-title":"Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective","volume":"65","author":"Zhang","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib41","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.addr.2008.02.011","article-title":"Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery","volume":"60","author":"Li","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.addr.2009.05.005","article-title":"Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin","volume":"61","author":"Davis","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib43","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nantod.2010.06.011","article-title":"Host-guest interactions mediated nanoassemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications","volume":"5","author":"Zhang","year":"2010","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib45","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/bj3080381","article-title":"Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells","volume":"308","author":"Sharom","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib47","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s11095-004-7675-5","article-title":"Effect of pluronic P85 on ATPase activity of drug efflux transporters","volume":"21","author":"Batrakova","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib48","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1054\/bjoc.2001.2165","article-title":"Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion","volume":"85","author":"Batrakova","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib49","first-page":"1","article-title":"Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2)","volume":"2","author":"Lalloo AKL","year":"2004","journal-title":"BMC Med."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib50","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1021\/mp400643p","article-title":"Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance","volume":"11","author":"Roy","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib51","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1023\/A:1018942823676","article-title":"Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2012.04.034","article-title":"Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes","volume":"161","author":"Montesinos","year":"2012","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.07.023_bib53","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1128\/JB.180.10.2630-2635.1998","article-title":"The periplasmic cyclodextrin binding protein CymE from Klebsiella oxytoca and its role in maltodextrin and cyclodextrin transport","volume":"180","author":"Pajatsch","year":"1998","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s002800050692","article-title":"Methyl-beta-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin","volume":"40","author":"Grosse","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biomaterials.2015.07.023_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-5793(03)00059-0","article-title":"Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells","volume":"536","author":"Yunomae","year":"2003","journal-title":"FEBS Lett."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215006055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215006055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:10:53Z","timestamp":1758903053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961215006055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":55,"alternative-id":["S0142961215006055"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.07.023","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}